By Kevin Penton ( December 13, 2018, 4:19 PM EST) -- Sen. Orrin Hatch, R-Utah, has introduced a bill that would amend his namesake Hatch-Waxman Act to hinder the ability of generic-drug makers to challenge patents in inter partes reviews before the Patent Trial and Appeal Board....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.